With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is hindered by its production, which involves both chemical synthesis and a slower enzyme-mediated process. A team of researchers from Nagoya University in Japan has successfully developed a cutting-edge technology for the production of fully chemically synthesized mRNA with high purity that cuts out the need for enzymes. Using this innovative technique, mRNA can be made faster and purer, making it possible to respond more swiftly to virus outbreaks and emerging diseases at an earlier stage.
This is an automated archive made by the Lemmit Bot.